Gada Italia updates


GADA Italia and Inari Medical: exclusive distribution in treatment of pulmonary embolism and peripheral circulation

New hope for INOCA patients suffering from angina

Impella 2.5: safe hemodynamic support in patients undergoing combined PCI and BAV

The impact of Neovasc Reducer on ischemic burden and myocardial perfusion: the JACC article

STEMI: a study published on Circulation confirms the efficiency of Impella CP on unloading the left ventricle

New partnership between GADA Italia and Lifetech Scientific Corporation

Neovasc Reducer™: clinical results in microvascular angina

The European experience of ACURATE neo in bicuspid and tricuspid aortic valves

Gada and Principia SGR announce a new partnership

VA ECMO-Impella Association: pulmonary flow improvement and effective left ventricular discharge

1-Year Outcomes of the using of the ACURATE neo transcatheter heart valve in 1,000 Patients

BIOTRAC, healthcare traceability solution, has its web page

Bactiguard: a new support against blood stream infections

The contribute of Impella during high-risk unprotected left main PCI

CE Mark for Terumo Ultimaster TANSEI

Percutaneous coronary intervention (PCI): CE marked indications for Terumo Ultimaster

CE Mark for Terumo Ultimaster TANSEI

CE Mark for LivaNova VNS Therapy SenTiva Generator

Antibiotics: use with care

New solutions for interventional systems: the agreement between Terumo and Medeon Biodesign

Impella: approval for expanded FDA indication for high risk percutaneous coronary intervention (PCI) procedures

Augmented Reality (AR) for transfusion and infusion: the AccuVein technology

Chemo-embolization: Terumo LifePearl® approved as a Class III device

The vital contribution of Impella® before revascularization

18 November 2017 – 10th European Antibiotic Awareness Day (EAAD)

New clinical study on Bactiguard’s central venous catheter shows promising results

Bactiguard and GADA: a new partnership for Italy

Dialysis: VitabranE, efficient aid to the management of anaemia

Transfusion: the debut of BIOTRAC at SIMTI

Impella 2.5: the results of Circulation Research study

Abiomed and Impella: historical result in the U.S.A.

Perfusionist and communication: the interview of GSD Magazine to Giulio Pavan (EPS)

Siena CEC: the latest news from cardiovascular

International Epilepsy Day

FDA: a new recognition for Abiomed

Important agreement between Terumo Corporation, Abbott and St. Jude Medical Ltd.

ECMO\ECLS: Gada in partnership with St. Jude Medical and Chalice Medical

SICCH 2016: Gada was present with its partners

GISE 2016: interventional cardiology at the Porto Antico of Genoa

Gada: the new web site is on line

GADA launches its newly expanded EPS Integrated Healthcare Services

EuroPCR 2016: a major new study on DAPT post-stent

Symetis announced the results for the SAVI TF Registry

The Abiomed Impella Therapy approved by FDA